Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

The market for advanced cell models is booming and expected to grow from $1.42 billion in 2022 to $5.29 billion by 2032. This surge is driven by the unique properties of advanced cell models: They can ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.